 |
|
|
19 September 2009 Cryosurgery recommended primary treatment option for prostate cancerThe key to perfecting the treatment came through an in-depth study that delved into to the molecular biology of prostate cancer and low temperature responses conducted by Dr. Robert Van Buskirk, Professor of Biological Sciences & Bioengineering. That's when Dr. William Hollister, a former BU graduate student now on the faculty of BCC, made a critical discovery, identifying a previously unrecognized form of cell death following freezing known as "apoptosis" in a population of dying cancer cells. While this team's research continues, the critical results of their ten years of patient treatment were recently published in the Journal of Urology. This landmark study demonstrated that 77% of patients treated at Allegheny General were cancer-free based on biopsy data. To date, over 40,000 prostate cancer patients have been treated with this therapy and the improved devices that have evolved. The American Urological Association recently issued a Best Practices Statement that recommends cryosurgery of the prostate as both a primary and salvage therapy for patients with PC. The success of this project is now leading directly to its expansion into other problematic diseases. Thus, the team is working now to bring this life-saving technology into the breast, kidney and lung cancer patients. NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|